New cancer clinical trial: Cabozantinib in Combination With Cetuximab in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Cancer

Published on: September 12, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share